期刊文献+

Src蛋白在膀胱移行细胞癌上的表达及其意义 被引量:4

Expression of Src Protein in Bladder Transitional Cell Carcinoma and Its Significance
下载PDF
导出
摘要 [目的]探讨Src蛋白在膀胱移行细胞癌(BTCC)组织中的表达及其意义。[方法]采取 HE染色和半定量RT-PCR检测c-Src基因在BTCC、癌旁组织及正常膀胱组织中的表达。[结果]BTCC(分浅表性膀胱癌和肌层浸润性膀胱癌两组)组织中c-Src基因在mRNA表达水平上明显增高,而在癌旁组织及正常膀胱组织中表达较低。c-Src mRNA的表达水平与BTCC患者肿瘤临床分期、病理分级,以及肿瘤有无复发具有相关性;其表达的强度与膀胱肿瘤的分化和分期密切相关,分化越低、临床分期越晚以及复发患者,其过表达越明显。[结论]c-Src的过表达或高表达与BTCC的侵袭、复发和转移密切相关。 [Objective] To explore the expression of Src protein in bladder transitional cell carcinoma (BTCC) and its clinical significance .[Methods] The expression of c-Src gene in BTCC ,adjacent cancer tissue and normal bladder tissue was detected by HE staining and semi-quantitative RT-PCR .[Results] The expres-sion of c-Src mRNA in BTCC tissue (superficial BTCC and muscular infiltrated BTCC ) obviously increased , while that in adjacent cancer tissue and normal bladder tissue decreased .The expression of c-Src mRNA was correlated with tumor clinical stage ,pathological grade and tumor recurrence of BTCC patients .The intensity of c-Src expression was closely related to tumor differentiation and stage .The patients with low differentia-tion ,late clinical stage and recurrence had obvious over-expression of c-Src .[Conclusion] Over-expression or high expression of c-Src is closely related to invasion ,recurrence and metastasis of BTCC .
出处 《医学临床研究》 CAS 2014年第1期44-45,49,共3页 Journal of Clinical Research
基金 湖南省卫生厅资助(编号2012-245)
关键词 膀胱肿瘤 病理学 移行细胞 病理学 蛋白质类 Urinary Bladder Neoplasms/PA Carcinoma,Transitional Cell/PA Proteins
  • 相关文献

同被引文献38

  • 1胡义德,钱桂生.人肺腺癌A549细胞系多重抗药性的形成[J].第三军医大学学报,1994,16(2):103-106. 被引量:8
  • 2郑锐,秦晓松,矢野圣二,曾根三郎,康健.抑制Src酪氨酸激酶对非小细胞肺癌细胞增殖的影响[J].中华肿瘤防治杂志,2006,13(11):826-830. 被引量:5
  • 3陈万青,张思维,李连弟,鲁凤珠,赵平,邹小农,陈永红.中国部分市县1998~2002年肺癌的发病与死亡[J].中国肿瘤,2006,15(9):570-574. 被引量:99
  • 4Sato H, Kita M, Seiki M. v-Src activates the expression of 92-k type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism reg-ulating gene expression independent of that inflammatory cyto- kines [ J ]. J Biol Chem, 1993,268 (31) :23460-23468.
  • 5Hakak Y, Martin CS. Ubipuitin-dependent degradation of active Src [ J ]. Cttrr Biol, 1999,9 ( 18 ) : 1039-1042.
  • 6Jones R J, Brunton VG, Frame MC. Adhesion-linked kinases in cancer;emphasis on src, focal adhesion kinase and PI3-kinase [J]. Eur J Cancer,2000,36(3) :1595-1606.
  • 7Munshi N, Groopman JE, Gill PS, et al. C-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular en- dothelial growth factor stimulation in Kaposi's sarcoma cells[ J]. J lmmunol, 2000,164 ( 3 ) : 1169 -1174.
  • 8Sane S, Shinohara T, Nishioka Y, et al. Symposium on molecular pathogencsis of respiratory diseases and its clinical implication. Molecular pathogertesis of lung cancer and its molecular targeted therapy[ J]. Intern Med,2001 ;40(2 ) : 167-170.
  • 9Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a po- tential target for diagnosis and therapy [ J ]. J Clin Oncol, 2002, 20:4368-4380.
  • 10Yano S, Nishioka Y, Goto H, et al. Molecular mechanisms of an- giogenesis in non-small cell lung cancer, and therapeutics targe- ting related mole-cules[ J]. Cancer Sci,2003,94(6) :479-485.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部